Dataset

   File(s) held in another repository
Title of Dataset
Data from: Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma
Author of Dataset
Yeung, Bonnie H. Y.1
Shek, Felix H.2
Wong, Chris K. C.1
Contact
Wong, Chris K. C.1
Date of Dataset Creation
2015-10-15
Description
Growing evidence has revealed high expression levels of stanniocalcin-1 (STC1) in different types of human cancers. Numerous experimental studies using cancer cell lines demonstrated the involvement of STC1 in inflammatory and apoptotic processes; however the role of STC1 in carcinogenesis remains elusive. Hepatocellular carcinoma (HCC) an exemplified model of inflammation-related cancer, represents a paradigm of studying the association between STC1 and tumor development. Therefore, we conducted a statistical analysis on the expression levels of STC1 using clinicopathological data from 216 HCC patients. We found that STC1 was upregulated in the tumor tissues and its expression levels was positively correlated with the levels of interleukin (IL)-6 and IL-8. Intriguingly tumors with greater expression levels of STC1 (tumor/normal ≥ 2) were significantly smaller than the lower level (tumor/normal<2) samples (p = 0.008). A pharmacological approach was implemented to reveal the functional correlation between STC1 and the ILs in the HCC cell-lines. IL-6 and IL-8 treatment of Hep3B cells induced STC1 expression. Lentiviral-based STC1 overexpression in Hep3B and MHCC-97L cells however showed inhibitory action on the pro-migratory effects of IL-6 and IL-8 and reduced size of tumor spheroids. The inhibitory effect of STC1 on tumor growth was confirmed in vivo using the stable STC1-overexpressing 97L cells on a mouse xenograft model. Genetic analysis of the xenografts derived from the STC1-overexpressing 97L cells, showed upregulation of the pro-apoptotic genes interleukin-12 and NOD-like receptor family, pyrin domain-containing 3. Collectively, the anti-inflammatory and pro-apoptotic functions of STC1 were suggested to relate its inhibitory effect on the growth of HCC cells. This study supports the notion that STC1 may be a potential therapeutic target for inflammatory tumors in HCC patients.
Citation
Yeung, BHY, Shek, FH, Lee, NP, Wong, CKC. (2015). Data from: Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma. [Data File]. All relevant data are within the paper and its Supporting Information files. Click on “Linked Publications” to access the publication and access supporting information on figshare at https://figshare.com/articles/_Stanniocalcin_1_Reduces_Tumor_Size_in_Human_Hepatocellular_Carcinoma_/1576606
Subject (RGC Codes)
M2 — Medicine, Dentistry & Health — 醫學, 牙科學及保健
  • 1204 — Cancer — 癌症
Subject (ANZSRC)
11 — MEDICAL AND HEALTH SCIENCES — 醫學與衛生科學
  • 1112 — ONCOLOGY AND CARCINOGENESIS — 腫瘤學與癌化
    • 111204 — Cancer Therapy (excl. Chemotherapy and Radiation Therapy) — 癌症治療
Keyword
Hep 3B cells
216 HCC patients
STC 1
STC 1 expression
tumor
expression levels
cancer cell lines
MHCC
mouse xenograft model
Human Hepatocellular Carcinoma
il
Affiliations
  1. Hong Kong Baptist Univ, Dept Biol, Kowloon Tong, Hong Kong, Peoples R China
  2. Univ Hong Kong, Dept Surg, Pokfulam, Hong Kong, Peoples R China